Abstract
Twenty-five-hydroxyvitamin D (25(OH)D) deficiency is common in chronic kidney disease (CKD) population. This study aimed to investigate the association between 25(OH)D and arterial stiffness in patients with non-dialysis-dependent CKD (CKD ND). Two hundred eighty-three patients aged ⩾18 years with CKD ND were divided into two groups: vitamin D deficient (25(OH)D<20 ng/ml) and vitamin D non-deficient (25(OH)D⩾20 ng/ml). Brachial-ankle pulse wave velocity (baPWV), a good marker for arterial stiffness, was calculated. The prevalence of vitamin D deficiency was 58.3% (165/283) and the mean concentration of 25(OH)D was 18±8 ng/ml. 25(OH)D inversely correlated with baPWV. Multiple linear regression analysis showed that vitamin D level was independently associated with baPWV in patients with CKD ND (β=−0.18, P<0.001). The model accounted for 45% (R2=0.45) of total variance of baPWV. Vitamin D deficiency is common in CKD ND, and a low 25(OH)D level is significantly associated with increased arterial stiffness.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007; 71: 31–38.
Chonchol M, Scragg R . 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int 2007; 71: 134–139.
Wang L, Song Y, Manson JE, Pilz S, März W, Michaëlsson K et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 2012; 5: 819–829.
Karras A, Haymann JP, Bozec E, Metzger M, Jacquot C, Maruani G et al. Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease. Hypertension 2012; 60: 1451–1457.
Kidney Disease Improving Global Outcomes. Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3: 19–62.
Holick MF . Vitamin D deficiency. N Engl J Med 2007; 357: 266–281.
Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007; 49: 1063–1069.
Brøndum-Jacobsen P, Benn M, Jensen GB, Nordestgaard BG . 25-hydroxyvitamin D levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arterioscler Thromb Vasc Biol 2012; 32: 2794–2802.
Poole KE, Loveridge N, Barker PJ, Halsall DJ, Rose C, Reeve J et al. Reduced vitamin D in acute stroke. Stroke 2006; 37: 243–245.
Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997; 96: 1755–1760.
Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Körfer R, Stehle P . Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 2003; 41: 105–112.
Shyy JY, Chien S . Role of integrins in endothelial mechanosensing of shear stress. Circ Res 2002; 91: 769–775.
Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359–364.
Yoon HE, Shin DI, Kim SJ, Koh ES, Hwang HS, Chung S et al. Brachial-ankle pulse wave velocity predicts decline in renal function and cardiovascular events in early stages of chronic kidney disease. Int J Med Sci 2013; 10: 1430–1436.
Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP . 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110: 229–238.
O'Connell TD, Berry JE, Jarvis AK, Somerman MJ, Simpson RU . 1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. Am J Physiol 1997; 272: H1751–H1758.
Ngai M, Lin V, Wong HC, Vathsala A, How P . Vitamin D status and its association with mineral and bone disorder in multi-ethnic chronic kidney disease population. Clin Nephrol 2014; 82: 231–239.
Jean G, Bresson E, Lorriaux C, Mayor B, Hurot JM, Deleaval P et al. Increased levels of serum parathyroid hormone and fibroblast growth factor-23 are the main factors associated with the progression of vascular calcification in long-hour hemodialysis patients. Nephron Clin Pract 2012; 120: 132–138.
Kawamoto R, Kohara K, Tabara Y, Miki T, Ohtsuka N, Kusunoki T et al. An association between decreased estimated glomerular filtration rate and arterial stiffness. Intern Med 2008; 47: 593–598.
Temmar M, Liabeuf S, Renard C, Czernichow S, Esper NE, Shahapuni I et al. Pulse wave velocity and vascular calcification at different stages of chronic kidney disease. J Hypertens 2010; 28: 163–169.
Wang MC, Tsai WC, Chen JY, Huang JJ . Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am J Kidney Dis 2005; 45: 494–501.
Thomas MC, Forbes JM, Cooper ME . Advanced glycation end products and diabetic nephropathy. Am J Ther 2005; 12: 562–572.
Mitchell GF, Dunlap ME, Warnica W, Ducharme A, Arnold JM, Tardif JC et al. Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy. Hypertension 2007; 49: 1271–1277.
Garg JP, Ellis R, Elliott WJ, Hasabou N, Chua D, Chertow GM et al. Angiotensin receptor blockade and arterial compliance in chronic kidney disease: a pilot study. Am J Nephrol 2005; 25: 393–399.
Cachofeiro V, Goicochea M, de Vinuesa SG, Oubiña P, Lahera V, Luño J . Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl 2008; 111: S4–S9.
Desjardins L, Liabeuf S, Renard C, Lenglet A, Lemke HD, Choukroun G et al. FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Osteoporos Int 2012; 23: 2017–2025.
Acknowledgements
This study was supported by grants from Zhejiang Medical Scientific Research Foundation (no. 2012KYB175) and Ningbo Natural Science Foundation (no. 2014A610245).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on European Journal of Clinical Nutrition website
Supplementary information
Rights and permissions
About this article
Cite this article
Luo, Q., Wang, L. & Gao, Y. Association between serum 25-hydroxyvitamin D and arterial stiffness in non-dialysis-dependent CKD. Eur J Clin Nutr 70, 274–276 (2016). https://doi.org/10.1038/ejcn.2015.146
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2015.146
This article is cited by
-
Serum 25-hydroxyvitamin D status was associated with brachial-ankle pulse wave velocity and mortality among peritoneal dialysis patients
European Journal of Clinical Nutrition (2021)
-
Neutrophil-lymphocyte ratio is associated with arterial stiffness in patients with peritoneal dialysis
BMC Nephrology (2016)